Supplementation of Persimmon Leaf Ameliorates Hyperglycemia, Dyslipidemia and Hepatic Fat Accumulation in Type 2 Diabetic Mice

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Jung, Un Ju ^a   Park, Yong Bok ^a   Kim, Sang Ryong ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACYL COENZYME A DESATURASE 1; ADENOSINE TRIPHOSPHATE CITRATE LYASE; ADIPONECTIN; ARYLDIALKYLPHOSPHATASE; CARNITINE PALMITOYLTRANSFERASE; CATALASE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; FAT DROPLET; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROGEN PEROXIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDATE PHOSPHATASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ACYL COENZYME A DESATURASE 1 GENE; ADENOSINE TRIPHOSPHATE CITRATE LYASE GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG MECHANISM; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY LIVER; GENE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE GENE; HOMEOSTATIC INDEX OF INSULIN RESISTANCE; HYPERGLYCEMIA; IN VIVO STUDY; INSULIN RESISTANCE; LIPID METABOLISM; LIPID PEROXIDATION; LIPOGENESIS; LIVER WEIGHT; MALE; METABOLIC PARAMETERS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PERSIMMON; PHOSPHATIDATE PHOSPHATASE GENE; PLANT LEAF; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ADIPONECTIN; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DIOSPYROS; DYSLIPIDEMIAS; FATTY LIVER; GENE EXPRESSION; GLUCOKINASE; GLYCOGEN; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT LEAVES; PLANT PREPARATIONS; PPAR GAMMA; RNA, MESSENGER; TRIGLYCERIDES;

DIOSPYROS; MUS;

EID: 84869017749     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049030     Document Type: Article

References (74)

1. Sun L, Zhang J, Lu X, Zhang L, Zhang Y, (2011) Evaluation to the antioxidant activity of total flavonoids extract from persimmon (Diospyros kaki L.) leaves. Food Chem Toxicol 49: 2689-2696.
2. Kameda K, Takaku T, Okuda H, Kimura Y, Okuda T, et al. (1987) Inhibitory effects of various flavonoids isolated from leaves of persimmon on angiotensin-converting enzyme activity. J Nat Prod 50: 680-683.
3. Kotani M, Matsumoto M, Fujita A, Higa S, Wang W, et al. (2000) Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol 106: 159-166.
4. Kawakami K, Aketa S, Sakai H, Watanabe Y, Nishida H, et al. (2011) Antihypertensive and vasorelaxant effects of water-soluble proanthocyanidins from persimmon leaf tea in spontaneously hypertensive rats. Biosci Biotechnol Biochem. 75: 1435-1439.
5. Kawakami K, Aketa S, Nakanami M, Iizuka S, Hirayama M, (2010) Major water-soluble polyphenols, proanthocyanidins, in leaves of persimmon (Diospyros kaki) and their alpha-amylase inhibitory activity. Biosci Biotechnol Biochem 74: 1380-1385.
6. Wang L, Xu ML, Rasmussen SK, Wang MH, (2011) Vomifoliol 9-O-α-arabinofuranosyl (1→6)-β-D-glucopyranoside from the leaves of Diospyros Kaki stimulates the glucose uptake in HepG2 and 3T3-L1 cells. Carbohydr Res 346: 1212-1216.
7. Thuong PT, Lee CH, Dao TT, Nguyen PH, Kim WG, et al. (2008) Triterpenoids from the leaves of Diospyros kaki (persimmon) and their inhibitory effects on protein tyrosine phosphatase 1B. J Nat Prod 71: 1775-1778.
8. Postic C, Girard J, (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118: 829-838.
9. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, et al. (2008) Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118: 789-800.
10. Lee JS, Lee MK, Ha TY, Bok SH, Park HM, et al. (2006) Supplementation of whole persimmon leaf improves lipid profiles and suppresses body weight gain in rats fed high-fat diet. Food Chem Toxicol 44: 1875-1883.
11. Shafrir E, (1992) Animal models of non-insulin dependent diabetes. Diabetes Metab Rev 8: 179-208.
12. Lee SC, Prosky L, DeVries JW, (1992) Determination of total, soluble, and insoluble dietary fiber in foods enzymatic-gravimetric method, MES-TRIS buffer: collaborative study. J Assoc Off Anal Chem Int 75: 395-416.
13. Singleton VL, Orthofer R, Lamuela-Raventos RM, (1999) Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol 299: 152-178.
14. Moreno MI, Isla MI, Sampietro AR, Vattuone MA, (2000) Comparison of the free radical-scavenging activity of propolis from several regions of Argentina. J Ethnopharmacol. 71: 109-114.
15. American Institute of Nutrition (1980) Report of ad hoc Committee on Standards for Nutritional Studies. J Nutr 110: 1717-1726.
16. American Institute of Nutrition (1977) Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr 107: 1340-1348.
17. Haffner SM, Miettinen H, Stern MP, (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20: 1087-1092.
18. Mackness MI, Arrol S, Durrington PN, (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286: 152-154.
19. Folch J, Lees M, Sloan-Stanley GH, (1956) A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509.
20. Seifter S, Dayton S, Novic B, Muntwyler E, (1950) The estimation of glycogen with the anthrone reagent. Arch Biochem Biophys 50: 191-200.
21. Wolff SP, (1994) Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxide. Methods Enzymol 233: 182-189.
22. Ohkawa H, Ohishi N, Yake K, (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
23. Hulcher FH, Oleson WH, (1973) Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res. 14: 625-631.
24. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
25. Davidson AL, Arion WJ, (1987) Factors underlying significant underestimations of glucokinase activity in crude liver extracts: Physiological implications of higher cellular activity. Arch Biochem Bophys 253: 156-167.
26. Newgard CB, Hirsch LJ, Foster DW, McGarry DJ, (1995) Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. J Biol Chem 258: 8046-8052.
27. Alegre M, Ciudad CJ, Fillat C, Guinovart JJ, (1988) Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction. Anal Biochem 173: 185-189.
28. Bentle LA, Lardy HA, (1976) Interaction of anions and divalent metal ions with phosphopyruvate carboxykinase. J Biol Chem 251: 2916-2921.
29. Carl MN, Lakshmanan MR, Porter JW, (1975) Fatty acid synthase from rat liver. Methods in Enzymology 35: 37-44.
30. Walton PA, Possmayer F, (1984) The role of Mg2+-dependent phosphatidate phosphohydrolase in pulmonary glycerolipid biosynthesis. Biochim Biophys Acta 796: 346-372.
31. Markwell MAK, McGroarty EJ, Bieber LL, Tolbert NE, (1973) The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. J Biol Chem 248: 3426-3432.
32. Lazarow PB, (1981) Assay of peroxisomal β-oxidation of fatty acids. Methods in Enzymology 72: 315-319.
33. Shapiro DJ, Nordstrom JL, Mitschelen JJ, Rodwell VW, Schimke RT, (1974) Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim Biophys Acta 370: 369-377.
34. Erickson SK, Schrewsbery MA, Brooks C, Meyer DJ, (1980) Rat liver acyl-coenzyme A:cholesterol acyltransferase: its regulation in vivo and some of properties in vitro. J Lipid Res 21: 930-941.
35. Marklund S, Marklund G, (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474.
36. Aebi H, (1974) Catalase in method of enzymatic analysis. New York, Academic Press 2: 673-684.
37. Paglia ED, Valentine WN, (1967) Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase. J Lab Clin Med 70: 158-169.
38. Chomzynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
39. Davis RC, Castellani LW, Hosseini M, Ben-Zeev O, Mao HZ, et al. (2010) Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice. Diabetes 59: 1616-1625.
40. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, et al. (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6: 87-97.
41. Tahrani AA, Bailey CJ, Del Prato S, Barnett AH, (2011) Management of type 2 diabetes: new and future developments in treatment. Lancet 378: 182-197.
42. Barthel A, Schmoll D, (2003) Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285: E685-E692.
43. Abdul-Ghani MA, Tripathy D, DeFronzo RA, (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29: 1130-1139.
44. Pal M, (2009) Recent advances in glucokinase activators for the treatment of type 2 diabetes. Drug Discov Today 14: 784-792.
45. Valentová K, Truong NT, Moncion A, de Waziers I, Ulrichová J, (2007) Induction of glucokinase mRNA by dietary phenolic compounds in rat liver cells in vitro. J Agric Food Chem 55: 7726-7731.
46. Cleasby ME, Dzamko N, Hegarty BD, Cooney GJ, Kraegen EW, et al. (2004) Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes 53: 3258-3266.
47. Mithieux G, Guignot L, Bordet J C, Wiernsperger N, (2002) Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes 51: 139-143.
48. Torres TP, Catlin RL, Chan R, Fujimoto Y, Sasaki N, et al. (2009) Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in Zucker diabetic fatty rats. Diabetes 58: 78-86.
49. O'Doherty RM, Lehman DL, Télémaque-Potts S, Newgard CB, (1999) Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48: 2022-2027.
50. Ferre T, Riu E, Franckhauser S, Agudo J, Bosch F, (2003) Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia 46: 1662-1668.
51. Nakamura A, Shimazaki H, Ohyama S, Eiki J, Terauchi Y, (2011) Effect of long-term treatment with a small-molecule glucokinase activator on glucose metabolism, lipid profiles and hepatic function. J Diabetes Invest 2: 276-279.
52. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, et al. (2000) Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141: 4021-4031.
53. Morán-Salvador E, López-Parra M, García-Alonso V, Titos E, Martínez-Clemente M, et al. (2011) Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. FASEB J. 25: 2538-2550.
54. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, et al. (2011) "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Proc Natl Acad Sci U S A 108: 5378-5383.
55. Wu M, Singh SB, Wang J, Chung CC, Salituro G, et al. (2011) Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc Natl Acad Sci U S A 108: 5378-5383.
56. Foster DW, (2004) The role of the carnitine system in human metabolism. Ann N Y Acad Sci 1033: 1-16.
57. Randle PJ, (1998) Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283.
58. Devine JH, Eubank DW, Clouthier DE, Tontonoz P, Spiegelman BM, et al. (1999) Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J Biol Chem 274: 13604-13612.
59. Hallakou S, Doaré L, Foufelle F, Kergoat M, Guerre-Millo M, et al. (1997) Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes. 46: 1393-1399.
60. Cadoudal T, Blouin JM, Collinet M, Fouque F, Tan GD, et al. (2007) Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Diabetologia. 50: 666-675.
61. Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, et al. (2003) Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111: 737-747.
62. Davies GF, Khandelwal RL, Wu L, Juurlink BH, Roesler WJ, (2001) Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism. Biochem Pharmacol 62: 1071-1079.
63. Glorian M, Duplus E, Beale EG, Scott DK, Granner DK, et al. (2001) A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. Biochimie 83: 933-943.
64. Giralt M, Park EA, Gurney AL, Liu JS, Hakimi P, et al. (1991) Identification of a thyroid hormone response element in the phosphoenolpyruvate carboxykinase (GTP) gene. Evidence for synergistic interaction between thyroid hormone and cAMP cis-regulatory elements. J Biol Chem 266: 21991-21996.
65. Lucas PC, O'Brien RM, Mitchell JA, Davis CM, Imai E, et al. (1991) A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene. Proc Natl Acad Sci U S A 88: 2184-2188.
66. Sasaki K, Cripe TP, Koch SR, Andreone TL, Petersen DD, et al. (1984) Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J Biol Chem 259: 15242-15251.
67. Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, et al. (2009) Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 284: 14809-14818.
68. Green K, Brand MD, Murphy MP, (2004) Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53: S110-S118.
69. Kumashiro N, Tamura Y, Uchida T, Ogihara T, Fujitani Y, et al. (2008) Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance. Diabetes 57: 2083-2091.
70. Suh Y H, Kim Y, Bang JH, Choi KS, Lee JW, et al. (2005) Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats. J Mol Endocrinol 34: 299-315.
71. Bai J, Rodriguez AM, Melendez JA, Cederbaum AI, (1999) Overexpression of catalase in cytosolic or mitochondrial compartment protects HepG2 cells against oxidative injury. J Biol Chem 274: 26217-26224.
72. Rosenblat M, Aviram M, (2009) Paraoxonases role in the prevention of cardiovascular diseases. Biofactors 35: 98-104.
73. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN, (1995) Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15: 1812-1818.
74. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, et al. (2003) Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. Diabetes Care 26: 2015-2020.